Jack Henry & Associates (JKHY)
NASDAQFinancialsInformation Technology ServicesSnapshot 2026-07-08
Reading JKHY? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track JKHY free→NASDAQFinancialsInformation Technology ServicesSnapshot 2026-07-08
Reading JKHY? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track JKHY free→QuarterlyIQ Insights · JKHY
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 14 valuation methods, at three horizons. Current price $147.37. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $147 the market pays 22× p/e — above the 17× p/e peer median but in line with its own 29× history. That premium reflects a durable franchise our peer-anchored $137 fair value understates; treat the 'expensive vs peers' read with medium confidence. Analysts target $165–$180. Note: our $137 fair value sits below the entire analyst range ($165–$180). Not investment advice.
$165.00 – $180.00 (median $170.00) · 5 analysts · as of 2026-06-29
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Cheaper than its own typical valuation.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $170.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $502.17 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $503.74 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $46.47 | — | — | TTM | high |
| graham number | 12M | $67.31 | — | — | TTM | high |
| Mgmt guidance | 12M | $110.27 | 16.2 | 6.83 | Mgmt | high |
| Peer P/B | 12M | $62.23 | 2.1 | 29.66 | TTM | high |
| Peer P/FCF | 12M | $137.52 | 13.6 | 10.11 | TTM | high |
| Peer P/E | 12M | $109.71 | 16.2 | 6.79 | TTM | high |
| Peer P/S | 12M | $117.94 | 3.4 | 34.95 | TTM | high |
| PEG | 12M | $60.45 | 8.9 | 6.79 | TTM | high |
| residual income | 12M | $47.68 | — | — | TTM | high |
| Own P/E history | 12M | $196.36 | 28.9 | 6.79 | TTM | high |
| triangulated | 12M | $116.08 | 16.2 | 7.18 | Triangulated | high |
| Mgmt guidance | 3Y | $126.57 | 16.2 | 7.83 | Mgmt(prov.) | medium |
| Peer P/B | 3Y | $86.36 | 2.1 | 41.16 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 3Y | $209.16 | 13.6 | 15.37 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $113.35 | 16.2 | 7.02 | Analyst | medium |
| Peer P/S | 3Y | $124.08 | 3.4 | 36.77 | guidance | medium |
| PEG | 3Y | $62.45 | 8.9 | 7.02 | Analyst | medium |
| Own P/E history | 3Y | $202.88 | 28.9 | 7.02 | Analyst | medium |
| Mgmt guidance | 5Y | $138.76 | 16.2 | 8.59 | Mgmt(prov.) | high |
| Peer P/B | 5Y | $107.44 | 2.1 | 51.21 | Hist. CAGR(prov.) | high |
| Peer P/FCF | 5Y | $276.61 | 13.6 | 20.33 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $110.60 | 16.2 | 6.85 | Analyst | high |
| Peer P/S | 5Y | $121.07 | 3.4 | 35.88 | guidance | high |
| PEG | 5Y | $60.94 | 8.9 | 6.85 | Analyst | high |
| Own P/E history | 5Y | $197.96 | 28.9 | 6.85 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.